Altogether, these results indicate that direct AMPK activation mediated by PXL770 in 13-month-old ALD mice with associated clinical phenotypes improved sciatic nerve axonal morphology, along with amelioration of defective locomotor function. The gene discussed is PRKAA1; the disease is adrenoleukodystrophy.